Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check5 days agoChange DetectedThe screenshot shows Revision: v3.3.4 added and Revision: v3.3.3 removed, indicating a minor UI/version update with no changes to study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew revision entry v3.3.3 has been added to the history. The HHS Vulnerability Disclosure link and the v3.3.2 revision entry have been removed from the footer.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded a new revision entry, Revision: v3.3.2, and removed the previous Revision: v3.2.0 from the Study Record Versions list.SummaryDifference0.1%

- Check63 days agoChange DetectedThe government funding operating-status notice/banner at the top of the page has been removed, eliminating a site-wide status alert without affecting the trial history data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check77 days agoChange DetectedMinor visual/layout updates to the Record History page with no changes to study data or version entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference11%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.